1. Home
  2. PROF vs NHS Comparison

PROF vs NHS Comparison

Compare PROF & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

N/A

Current Price

$7.52

Market Cap

230.4M

Sector

Health Care

ML Signal

N/A

Logo Neuberger Berman High Yield Strategies Fund

NHS

Neuberger Berman High Yield Strategies Fund

N/A

Current Price

$7.16

Market Cap

217.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PROF
NHS
Founded
N/A
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
230.4M
217.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PROF
NHS
Price
$7.52
$7.16
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
150.0K
111.8K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
13.44%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,297,000.00
N/A
Revenue This Year
$64.23
N/A
Revenue Next Year
$113.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
67.94
N/A
52 Week Low
$3.76
$6.95
52 Week High
$7.99
$9.17

Technical Indicators

Market Signals
Indicator
PROF
NHS
Relative Strength Index (RSI) 58.87 44.12
Support Level $7.02 $7.05
Resistance Level $7.60 $7.34
Average True Range (ATR) 0.39 0.05
MACD -0.02 -0.00
Stochastic Oscillator 65.52 43.10

Price Performance

Historical Comparison
PROF
NHS

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

Share on Social Networks: